Ex vivo generation of highly purified and activated natural killer cells from human peripheral blood.

Ex vivo generation of highly purified and activated natural killer cells from human peripheral blood.
复制标题

从人外周血中离体产生高度纯化和活化的自然杀伤细胞。

DOI:
10.1089/hgtb.2012.183
复制
发表时间:
2013
期刊:
Hum Gene Ther Methods.
影响因子:
--
通讯作者:
Yonemitsu Y.
Yonemitsu Y.
中科院分区:
--
文献类型:
--
作者:
Saito S;Harada Y;Morodomi Y;Onimaru M;Yoshida K;Kyuragi R;Matsubara H;Yonemitsu Y.

文献摘要

参考文献

被引文献

相似文献

使用自然杀伤(NK)细胞的连续免疫疗法已经成为难治性恶性肿瘤的有希望的治疗;然而,关于效应细胞的短缺和有限的抗癌效力,仍然存在许多困难。我们在此建立了一种简单的无饲养层的方法,从人外周血来源的单核细胞(PBMC)中产生纯化的(>90%)和高度活化的NK细胞。在几个参数中,我们发现CD 3耗竭、高剂量白细胞介素(IL)-2和使用特定培养基足以从PBMC中获得高度纯化、扩增(约200倍)和活化的CD 3 −/CD 56 +NK细胞,我们将其命名为Zenithal-NK(Z-NK)细胞。几乎所有的Z-NK细胞都表达淋巴细胞活化的标志物CD 69,并显示出活化受体的显著高表达(即,NKG 2D)、干扰素-γ、穿孔素和颗粒酶B。重要的是,在效靶比为1:1的情况下,仅反应2小时就足以杀死几乎所有的K562细胞,并且在荷瘤小鼠体内也复制了抗肿瘤活性。细胞溶解是特定的各种肿瘤细胞,但不为正常细胞,不论MHC I类表达。这些发现有力地表明,Z-NK细胞是纯化的、扩增的和接近完全活化的人NK细胞,并且值得在临床环境中进一步研究。
Adoptive immunotherapy using natural killer (NK) cells has been a promising treatment for intractable malignancies; however, there remain a number of difficulties with respect to the shortage and limited anticancer potency of the effector cells. We here established a simple feeder-free method to generate purified (>90%) and highly activated NK cells from human peripheral blood-derived mononuclear cells (PBMCs). Among the several parameters, we found that CD3 depletion, high-dose interleukin (IL)-2, and use of a specific culture medium were sufficient to obtain highly purified, expanded (∼200-fold) and activated CD3−/CD56+NK cells from PBMCs, which we designated zenithal-NK (Z-NK) cells. Almost all Z-NK cells expressed the lymphocyte-activated marker CD69 and showed dramatically high expression of activation receptors (i.e., NKG2D), interferon-γ, perforin, and granzyme B. Importantly, only 2 hours of reaction at an effector/target ratio of 1:1 was sufficient to kill almost all K562 cells, and the antitumor activity was also replicated in tumor-bearing micein vivo. Cytolysis was specific for various tumor cells, but not for normal cells, irrespective of MHC class I expression. These findings strongly indicate that Z-NK cells are purified, expanded, and near-fully activated human NK cells and warrant further investigation in a clinical setting.
DOI: --
发表时间: 1991
期刊: Journal of clinical & laboratory immunology
影响因子: --
作者:
M. N. Aparicio;H. Verspaget;A. Peña;C. Lamers
通讯作者: C. Lamers
过继性 T 细胞治疗后肿瘤监测减少。
DOI: 10.1158/0008-5472.can-06-4372
发表时间: 2007
期刊: Cancer research
影响因子: 11.2
作者:
M. Matter;Viktor Pavelic;D. Pinschewer;Sabine Mumprecht;Bruno Eschli;Tsanan Giroglou;D. von Laer;A. Ochsenbein
通讯作者: A. Ochsenbein
DOI: 10.3109/14653249.2010.515582
发表时间: 2011-01
期刊: Cytotherapy
影响因子: 4.5
作者:
Geller MA;Cooley S;Judson PL;Ghebre R;Carson LF;Argenta PA;Jonson AL;Panoskaltsis-Mortari A;Curtsinger J;McKenna D;Dusenbery K;Bliss R;Downs LS;Miller JS
通讯作者: Miller JS
DOI: 10.4049/jimmunol.0803845
发表时间: 2009-10-01
影响因子: 4.4
作者:
Komaru, Atsushi;Ueda, Yasuji;Yonemitsu, Yoshikazu
通讯作者: Yonemitsu, Yoshikazu
DOI: --
发表时间: 1998
期刊: Archives of Otolaryngology - Head and Neck Surgery
影响因子: --
作者:
MD Francisco M. Gonza´lez;PhD Juan A. Vargas;PhD Cristo´bal Lo´pez;PhD Raquel Castejo´n Md;BSc Carmen Gorriz;MD Rafael Ramı´rez;PhD Isabel Milla´n Md;MS Alberto Dura´ntez
通讯作者: MS Alberto Dura´ntez